"RNA, Ribosomal, 16S" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.
| Descriptor ID |
D012336
|
| MeSH Number(s) |
D13.444.735.686.670
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "RNA, Ribosomal, 16S".
Below are MeSH descriptors whose meaning is more specific than "RNA, Ribosomal, 16S".
This graph shows the total number of publications written about "RNA, Ribosomal, 16S" by people in this website by year, and whether "RNA, Ribosomal, 16S" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 3 | 3 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 3 | 3 |
| 2011 | 1 | 4 | 5 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 5 | 6 |
| 2017 | 6 | 111 | 117 |
| 2018 | 11 | 109 | 120 |
| 2019 | 1 | 31 | 32 |
| 2020 | 1 | 4 | 5 |
| 2021 | 1 | 7 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "RNA, Ribosomal, 16S" by people in Profiles.
-
Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types. Microbes Infect. 2022 02; 24(1):104880.
-
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome. mBio. 2021 08 31; 12(4):e0177721.
-
Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose. Cell Rep. 2021 08 31; 36(9):109637.
-
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes. 2021 07 22; 7(1):61.
-
The Gut Microbiota of Critically Ill Patients With COVID-19. Front Cell Infect Microbiol. 2021; 11:670424.
-
SARS-CoV-2 detection status associates with bacterial community composition in patients and the hospital environment. Microbiome. 2021 06 08; 9(1):132.
-
Gonococcal endocarditis: A rare manifestation of a common disease in the COVID-19 era. Int J STD AIDS. 2021 10; 32(11):1078-1080.
-
Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol. BMJ Open. 2021 05 05; 11(5):e047069.
-
SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition. Sci Rep. 2021 04 26; 11(1):8922.
-
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing. Int J Environ Res Public Health. 2021 02 23; 18(4).